These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36504457)

  • 1. A novel colony-stimulating factor 1 (CSF1) translocation  involving human endogenous retroviral element in a tenosynovial giant cell tumor.
    Lipplaa A; Meijer D; van de Sande MAJ; Gelderblom H; Bovée JVMG; Mei H; Szuhai K
    Genes Chromosomes Cancer; 2023 Apr; 62(4):223-230. PubMed ID: 36504457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of CSF1 immunohistochemistry in tenosynovial giant cell tumor for differentiating from giant cell-rich tumors and tumor-like lesions of bone and soft tissue.
    Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Shimizu J; Murahashi Y; Emori M; Hasegawa T
    Diagn Pathol; 2022 Nov; 17(1):88. PubMed ID: 36320082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutations.
    Tsuda Y; Hirata M; Katayama K; Motoi T; Matsubara D; Oda Y; Fujita M; Kobayashi H; Kawano H; Nishida Y; Sakai T; Okuma T; Goto T; Ogura K; Kawai A; Ae K; Anazawa U; Suehara Y; Iwata S; Miyano S; Imoto S; Shibata T; Nakagawa H; Yamaguchi R; Tanaka S; Matsuda K
    Int J Cancer; 2019 Dec; 145(12):3276-3284. PubMed ID: 31107544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of CSF1 rearrangements deleting the 3' UTR in tenosynovial giant cell tumors.
    Ho J; Peters T; Dickson BC; Swanson D; Fernandez A; Frova-Seguin A; Valentin MA; Schramm U; Sultan M; Nielsen TO; Demicco EG
    Genes Chromosomes Cancer; 2020 Feb; 59(2):96-105. PubMed ID: 31469468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular Tenosynovial Giant Cell Tumor Harboring a Novel
    Mejbel H; Siegal GP; Wei S
    Int J Surg Pathol; 2022 May; 30(3):335-338. PubMed ID: 34657489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel CSF1-S100A10 fusion gene and CSF1 transcript identified by RNA sequencing in tenosynovial giant cell tumors.
    Panagopoulos I; Brandal P; Gorunova L; Bjerkehagen B; Heim S
    Int J Oncol; 2014 May; 44(5):1425-32. PubMed ID: 24604026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical and biogenetic features of diffuse-type tenosynovial giant cell tumors: the potential roles of cyclin A, P53, and deletion of 15q in sarcomatous transformation.
    Huang HY; West RB; Tzeng CC; van de Rijn M; Wang JW; Chou SC; Huang WW; Eng HL; Lin CN; Yu SC; Wu JM; Lu CC; Li CF
    Clin Cancer Res; 2008 Oct; 14(19):6023-32. PubMed ID: 18829481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
    Mastboom MJL; Hoek DM; Bovée JVMG; van de Sande MAJ; Szuhai K
    Histopathology; 2019 Jan; 74(2):332-340. PubMed ID: 30152874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal Treatment for Tenosynovial Giant Cell Tumor of the Hand.
    Kitagawa Y; Takai S
    J Nippon Med Sch; 2020 Sep; 87(4):184-190. PubMed ID: 32350187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular identification of COL6A3-CSF1 fusion transcripts in tenosynovial giant cell tumors.
    Möller E; Mandahl N; Mertens F; Panagopoulos I
    Genes Chromosomes Cancer; 2008 Jan; 47(1):21-5. PubMed ID: 17918257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenosynovial Giant Cell Tumor, Localized Type With Extensive Chondroid Metaplasia: A Case Report With Immunohistochemical and Molecular Genetic Analysis.
    Nagase M; Araki A; Ishikawa N; Nagano N; Fujimoto M; Biyajima K; Yamagami N; Yamamoto S; Maruyama R
    Int J Surg Pathol; 2020 Jun; 28(4):447-453. PubMed ID: 31771368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.
    West RB; Rubin BP; Miller MA; Subramanian S; Kaygusuz G; Montgomery K; Zhu S; Marinelli RJ; De Luca A; Downs-Kelly E; Goldblum JR; Corless CL; Brown PO; Gilks CB; Nielsen TO; Huntsman D; van de Rijn M
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):690-5. PubMed ID: 16407111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of colony-stimulating factor 1 in the neoplastic process of tenosynovial giant cell tumor.
    Tap WD; Healey JH
    Tumour Biol; 2022; 44(1):239-248. PubMed ID: 36502356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAscope CSF1 chromogenic in situ hybridization: a potentially useful tool in the differential diagnosis of tenosynovial giant cell tumors.
    Thangaiah JJ; Koepplin JW; Folpe AL
    Hum Pathol; 2021 Sep; 115():1-9. PubMed ID: 34058245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.
    Cupp JS; Miller MA; Montgomery KD; Nielsen TO; O'Connell JX; Huntsman D; van de Rijn M; Gilks CB; West RB
    Am J Surg Pathol; 2007 Jun; 31(6):970-6. PubMed ID: 17527089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant Tenosynovial Giant Cell Tumor: The True "Synovial Sarcoma?" A Clinicopathologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases, Supporting Origin from Synoviocytes.
    Al-Ibraheemi A; Ahrens WA; Fritchie K; Dong J; Oliveira AM; Balzer B; Folpe AL
    Mod Pathol; 2019 Feb; 32(2):242-251. PubMed ID: 30206409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of a novel cell line, NCC-TGCT1-C1, derived from a patient with tenosynovial giant cell tumor.
    Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
    Hum Cell; 2021 Jan; 34(1):254-259. PubMed ID: 32886306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. t(1;2)-Positive Localized Tenosynovial Giant Cell Tumor With Bone Invasion.
    Nakayama S; Nishio J; Aoki M; Nabeshima K; Yamamoto T
    In Vivo; 2022; 36(5):2525-2529. PubMed ID: 36099115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF1 expression in xanthogranulomatous epithelial tumor/keratin-positive giant cell-rich tumor.
    Dehner CA; Lo YC; Chopra S; Demicco EG; He K; Hirbe AC; Folpe AL; Chrisinger JSA
    Hum Pathol; 2024 Jan; 143():1-4. PubMed ID: 37993023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects of Treating Tenosynovial Giant Cell Tumor through Pexidartinib: A Review.
    Alsayadi YMMA; Chawla PA
    Anticancer Agents Med Chem; 2021; 21(12):1510-1519. PubMed ID: 33143617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.